| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 1.197 | 339 | 4.021 | 34.620 | 31.843 | 57.433 | 74.101 | 64.050 | 115.716 |
| Total Income - EUR | - | 1.197 | 340 | 4.021 | 34.620 | 33.158 | 57.433 | 74.101 | 64.050 | 116.346 |
| Total Expenses - EUR | - | 108 | 134 | 2.801 | 21.923 | 23.370 | 37.194 | 48.333 | 41.224 | 54.619 |
| Gross Profit/Loss - EUR | - | 1.089 | 206 | 1.220 | 12.697 | 9.788 | 20.239 | 25.769 | 22.826 | 61.727 |
| Net Profit/Loss - EUR | - | 1.053 | 195 | 1.196 | 12.350 | 9.598 | 19.918 | 25.082 | 22.199 | 58.326 |
| Employees | - | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Oftalmoclinique Vision Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 122 | 0 | 2.693 | 55 | 40 | 26 | 12 | 0 | 0 |
| Current Assets | - | 1.234 | 518 | 7.505 | 14.027 | 21.940 | 22.823 | 48.522 | 29.186 | 63.214 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 623 | 0 | 158 | 119 | 22.021 | 137 | 3.597 |
| Cash | - | 1.234 | 518 | 6.882 | 14.027 | 21.782 | 22.704 | 26.500 | 29.049 | 59.616 |
| Shareholders Funds | - | 1.097 | 248 | 1.248 | 12.400 | 9.647 | 19.967 | 25.130 | 22.247 | 58.374 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 259 | 270 | 8.951 | 1.682 | 12.333 | 2.882 | 23.403 | 7.170 | 5.070 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Oftalmoclinique Vision Srl